EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2)
Clinical trial NCT04335032 · UNKNOWN
Trial details
- NCT number
- NCT04335032
- Sponsor
- S.L.A. Pharma AG
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-08
- Primary completion
- 2021-11-30
- Enrollment
- 284
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.